Amarin Corp. Plc (AMRN)
14.52
-0.48
(-3.20%)
USD |
NASDAQ |
Mar 20, 16:00
14.44
-0.08
(-0.55%)
After-Hours: 20:00
Amarin Research and Development Expense (Quarterly) : 4.662M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Trinity Biotech Plc | 0.8133M |
| Alkermes Plc | 91.74M |
| Jazz Pharmaceuticals Plc | 213.91M |
| Perrigo Co. Plc | 21.80M |
| Biodexa Pharmaceuticals Plc | -- |